SCHEMBL310041

SCHEMBL310041

C[SiH](Oc1ccccc1)Oc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 P22748 1/20 0.48
LTA4H P09960 4/20 0.45
TSHR P16473 3/20 0.45
KCNA3 P22001 1/20 0.38
CA5A P35218 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
NR1H2 P55055 1/20 0.35
BAX Q07812 1/20 0.35
MAOA P21397 1/20 0.35
LMNA P02545 2/20 0.34
HTR1B P28222 2/20 0.34
HTR1D P28221 1/20 0.34
MAOB P27338 1/20 0.34
TAAR1 Q96RJ0 1/20 0.33
ALDH1A1 P00352 1/20 0.33
RECQL P46063 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
ALOX12 P18054 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1609075 0.87 CA4 (0.48) CA4LTA4HTSHRKCNA3CA5A
SCHEMBL28665027 0.82 TSHR (0.43) CA4TSHRCA5ACA5BMAOA
SCHEMBL2354326 0.82 CA4 (0.48) CA4LTA4HTSHRKCNA3CA5A
SCHEMBL19927500 0.81 LTA4H (0.42) CA4LTA4HTSHRKCNA3LMNA
SCHEMBL23771854 0.78 CA4 (0.43) CA4LTA4HTSHRKCNA3CA5A
SCHEMBL5031062 0.78 CA4 (0.43) CA4LTA4HTSHRKCNA3CA5A
SCHEMBL27704021 0.78 CA4 (0.50) CA4LTA4HTSHRKCNA3CA5A
SCHEMBL28645955 0.76 KCNA3 (0.50) LTA4HKCNA3HTR1BHTR1DTAAR1
SCHEMBL707987 0.76 CA4 (0.42) CA4LTA4HTSHRKCNA3CA5A
SCHEMBL275159 0.75 LTA4H (0.50) CA4LTA4HTSHRKCNA3CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2864381-A1 PROCESS FOR PRODUCING A COMPOSITE MATERIAL BASF SE (DE) 2015-04-29 EP claimed
US-8865858-B2 Process for producing a composite material BASF SE (DE) 2014-10-21 US claimed
WO-2014001273-A1 PROCESS FOR PRODUCING A COMPOSITE MATERIAL BASF SE (DE) 2014-01-03 WO claimed
US-20130345385-A1 PROCESS FOR PRODUCING A COMPOSITE MATERIAL BASF SE (DE) 2013-12-26 US claimed
EP-1225194-B2 Method of forming a dielectric interlayer film with organosilicon precursors AIR PROD & CHEM (US) 2013-09-18 EP claimed
EP-1225194-B1 Method of forming a dielectric interlayer film with organosilicon precursors AIR PROD & CHEM (US) 2008-10-01 EP claimed
US-20070282121-A1 INTERMEDIATES FOR THE SYNTHESIS OF POLYPROPIONATE ANTIBIOTICS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-12-06 US claimed
US-7297807-B1 Intermediates for the synthesis of polypropionate antibiotics THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2007-11-20 US claimed
US-6583048-B2 Chemical vapor deposition from a silyl ether, a silyl ether oligomer, or an organosilicon compound containing one or more reactive groups, to form an interlayer dielectric film having a dielectric constant of 3.5 or less. AIR PRODUCTS AND CHEMICALS, INC. 2003-06-24 US claimed
US-20020142579-A1 ORGANOSILICON PRECURSORS FOR INTERLAYER DIELECTRIC FILMS WITH LOW DIELECTRIC CONSTANTS VERSUM MATERIALS US, LLC 2002-10-03 US claimed
EP-1225194-A2 Method of forming a dielectric interlayer film with organosilicon precursors AIR PRODUCTS AND CHEMICALS, INC. (US) 2002-07-24 EP claimed
EP-4703367-A1 RUTHENIUM COMPLEX, METHOD FOR PRODUCING SILYL GROUP-CONTAINING COMPOUND, SILYL GROUP-CONTAINING POLYMER MIXTURE, CURABLE COMPOSITION, AND CURED PRODUCT Kaneka Corporation (JP) 2026-03-04 EP disclosed
EP-4703406-A1 HYDROLYZABLE SILYL GROUP-CONTAINING POLYOXYALKYLENE POLYMER, CURABLE COMPOSITION, AND CURED PRODUCT Kaneka Corporation (JP) 2026-03-04 EP disclosed
US-20260049176-A1 HYDROLYZABLE SILYL GROUP-CONTAINING POLYOXYALKYLENE POLYMER, CURABLE COMPOSITION, AND CURED PRODUCT KANEKA CORPORATION (JP) 2026-02-19 US disclosed
US-20260049182-A1 RUTHENIUM COMPLEX, METHOD FOR PRODUCING SILYL GROUP-CONTAINING COMPOUND, SILYL GROUP-CONTAINING POLYMER MIXTURE, CURABLE COMPOSITION, AND CURED PRODUCT KANEKA CORPORATION (JP) 2026-02-19 US disclosed
EP-0824127-A2 Water-type dispersion composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1998-02-18 EP disclosed
EP-0693513-A2 Process for purifying a polyether ASAHI GLASS COMPANY LTD. (JP) 1996-01-24 EP disclosed
US-4565873-A ADHESION PROMOTERS CIBA-GEIGY CORPORATION (US) 1986-01-21 US disclosed
US-4364808-A ADHESION PROMOTERS CIBA-GEIGY CORPORATION (US) 1982-12-21 US disclosed
US-4271074-A Silanes containing imide groups CIBA-GEIGY CORPORATION (US) 1981-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070282121-A1 INTERMEDIATES FOR THE SYNTHESIS OF POLYPROPIONATE ANTIBIOTICS DHPS, EMG1, RPN1 CA4 4411/4885LTA4H 2060/4885TSHR 2496/4885
US-20260049176-A1 HYDROLYZABLE SILYL GROUP-CONTAINING POLYOXYALKYLENE POLYMER, CURABLE COMPOSITION, AND CURED PRODUCT PSMA1, LIPA, SGMS1 CA4 2671/4885LTA4H 124/4885TSHR 4563/4885
US-20260049182-A1 RUTHENIUM COMPLEX, METHOD FOR PRODUCING SILYL GROUP-CONTAINING COMPOUND, SILYL GROUP-CONTAINING POLYMER MIXTURE, CURABLE COMPOSITION, AND CURED PRODUCT ILK, CROCC, SEM1 CA4 1281/4885LTA4H 314/4885TSHR 4869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.